The nation of Zimbabwe has rejected a substantial US healthcare agreement valued at 367 million US dollars (£272m) over five years over Washington's demand for sensitive data.
The decision was revealed following a official document from December was disclosed, revealing that President Emmerson Mnangagwa believed the deal was "skewed".
A government spokesman has since stated that the United States was seeking genetic material for scientific study and commercial gain while was unwilling to share the resulting advantages from future vaccines.
"We are forced to start the challenging and unfortunate task of scaling back our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for further talks to reach a deal acceptable to all parties so the country's vital HIV programme can proceed.
Broader Background
This development comes after a similar situation in Kenya, where a high court blocked a related health funding agreement following concerns were raised about the security of citizens' health data.
Since returning to the presidency last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump stated its spending was "wasteful" and his government was seeking direct bilateral deals to boost transparency and accountability.
As per statements, Sixteen African countries have to date agreed to similar health pacts, representing over $18.3bn in new funding.
Specifics of the Rejected Agreement
The money for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment via American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information indefinitely, without any corresponding assurance of access to any scientific breakthroughs – like new medicines or tests – that could result from that provided information," he stated.
"Put simply, our country would supply the raw materials for scientific discovery with no certainty that the end products would be accessible to our population should a future pandemic arise."
National Interest and Global Health
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of one-on-one deals were disrupting structures already established through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing framework created to deal with potential global health emergencies.
"This mechanism is intended to guarantee that when a nation contributes its information, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to develop them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.
"We are open to further discussions with our American counterparts on how future co-operation could be designed in a manner that honours the sovereignty and interests of both nations."
Medical Community Response
A leading public health body stated it recognised the official position, but recommended that negotiations need to persist given that much of the country's Aids initiatives were funded by external financing.
"If technical issues exist, including those relating to information security or agreement terms, these can often be resolved via technical clarification and mutually agreed protections," the group added.
This impasse highlights the continuing tensions between receiving vital international aid and protecting a country's data in an ever more interconnected world.